PMID- 35155038 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220215 IS - 2168-8184 (Print) IS - 2168-8184 (Electronic) IS - 2168-8184 (Linking) VI - 14 IP - 2 DP - 2022 Feb TI - Methazolamide Associated Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis in a Female of Caucasian Descent. PG - e21864 LID - 10.7759/cureus.21864 [doi] LID - e21864 AB - Stevens-Johnson syndrome (SJS) is a potentially life-threatening cutaneous disorder that is characterized by skin erosions. It lies on a spectrum of varying severity with toxic epidermal necrolysis (TEN) being the most severe form. An overlap of the syndromes is known as SJS/TEN. These disorders are most often caused by a drug reaction, with anti-epileptic drugs and sulfonamide drugs as the common offending agents. Rarely, the syndrome can be due to a reaction to carbonic anhydrase inhibitors such as methazolamide. When present in association with methazolamide, the syndrome has only been known to occur in patients of Asian descent with human leukocyte antigen (HLA) mutations. We present a case of methazolamide-associated Stevens-Johnson syndrome in a patient of Caucasian descent. CI - Copyright (c) 2022, Baluch et al. FAU - Baluch, Amarah AU - Baluch A AD - Internal Medicine, State University of New York Upstate Medical University, Syracuse, USA. FAU - Chohan, Moeed R AU - Chohan MR AD - Internal Medicine, State University of New York Upstate Medical University, Syracuse, USA. FAU - Warda, Katerina AU - Warda K AD - Internal Medicine, State University of New York Upstate Medical University, Syracuse, USA. FAU - Sippy, Rishab AU - Sippy R AD - Internal Medicine, State University of New York Upstate Medical University, Syracuse, USA. FAU - Sandhu, Jasmine AU - Sandhu J AD - Internal Medicine, State University of New York Upstate Medical University, Syracuse, USA. LA - eng PT - Case Reports DEP - 20220203 PL - United States TA - Cureus JT - Cureus JID - 101596737 PMC - PMC8815805 OTO - NOTNLM OT - cutaneous adverse drug reaction OT - hla OT - methazolamide OT - stevens johnson OT - toxic epidermal necrolysis COIS- The authors have declared that no competing interests exist. EDAT- 2022/02/15 06:00 MHDA- 2022/02/15 06:01 PMCR- 2022/02/03 CRDT- 2022/02/14 05:33 PHST- 2022/02/03 00:00 [accepted] PHST- 2022/02/14 05:33 [entrez] PHST- 2022/02/15 06:00 [pubmed] PHST- 2022/02/15 06:01 [medline] PHST- 2022/02/03 00:00 [pmc-release] AID - 10.7759/cureus.21864 [doi] PST - epublish SO - Cureus. 2022 Feb 3;14(2):e21864. doi: 10.7759/cureus.21864. eCollection 2022 Feb.